Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Clinical Trial Imaging Market, by Region, 2018-2027 (USD Billion)
1.2.2. Clinical Trial Imaging Market, by Product & Services, 2018-2027 (USD Billion)
1.2.3. Clinical Trial Imaging Market, by Modality, 2018-2027 (USD Billion)
1.2.4. Clinical Trial Imaging Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Trial Imaging Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Trial Imaging Market Dynamics
3.1. Clinical Trial Imaging Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Clinical Trial Imaging Market: Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Clinical Trial Imaging Market, by Product & Services
5.1. Market Snapshot
5.2. Global Clinical Trial Imaging Market by Product & Services, Performance - Potential Analysis
5.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Product & Services 2017-2027 (USD Billion)
5.4. Clinical Trial Imaging Market, Sub Segment Analysis
5.4.1. Services
5.4.2. Software
Chapter 6. Global Clinical Trial Imaging Market, by Modality
6.1. Market Snapshot
6.2. Global Clinical Trial Imaging Market by Modality, Performance - Potential Analysis
6.3. Global Clinical Trial Imaging Market Estimates & Forecasts by Modality 2017-2027 (USD Billion)
6.4. Clinical Trial Imaging Market, Sub Segment Analysis
6.4.1. Computed Tomography
6.4.2. Magnetic Resonance Imaging
6.4.3. Positron Emission Tomography
6.4.4. Ultrasound
6.4.5. X-Ray
6.4.6. Echocardiography
6.4.7. Others
Chapter 7. Global Clinical Trial Imaging Market, by End-User
7.1. Market Snapshot
7.2. Global Clinical Trial Imaging Market by End-User, Performance - Potential Analysis
7.3. Global Clinical Trial Imaging Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4. Clinical Trial Imaging Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Specialty Clinics
7.4.3. Ambulatory Surgical Centers
7.4.4. Research & Academic Institutions
Chapter 8. Global Clinical Trial Imaging Market, Regional Analysis
8.1. Clinical Trial Imaging Market, Regional Market Snapshot
8.2. North America Clinical Trial Imaging Market
8.2.1.1. U.S. Clinical Trial Imaging Market
8.2.1.2. Product & Services breakdown estimates & forecasts, 2017-2027
8.2.1.3. Modality breakdown estimates & forecasts, 2017-2027
8.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Clinical Trial Imaging Market
8.3. Europe Clinical Trial Imaging Market Snapshot
8.3.1. U.K. Clinical Trial Imaging Market
8.3.2. Germany Clinical Trial Imaging Market
8.3.3. France Clinical Trial Imaging Market
8.3.4. Spain Clinical Trial Imaging Market
8.3.5. Italy Clinical Trial Imaging Market
8.3.6. Rest of Europe Clinical Trial Imaging Market
8.4. Asia-Pacific Clinical Trial Imaging Market Snapshot
8.4.1. China Clinical Trial Imaging Market
8.4.2. India Clinical Trial Imaging Market
8.4.3. Japan Clinical Trial Imaging Market
8.4.4. Australia Clinical Trial Imaging Market
8.4.5. South Korea Clinical Trial Imaging Market
8.4.6. Rest of Asia Pacific Clinical Trial Imaging Market
8.5. Latin America Clinical Trial Imaging Market Snapshot
8.5.1. Brazil Clinical Trial Imaging Market
8.5.2. Mexico Clinical Trial Imaging Market
8.6. Rest of The World Clinical Trial Imaging Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bioclinica Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product & Services Summary
9.2.1.5. Recent Developments
9.2.2. Parexel International Corporation
9.2.3. Icon PLC
9.2.4. Biomedical Systems Corporation
9.2.5. Biotelemetry, Inc.
9.2.6. Cardiovascular Imaging Technologies, LLC
9.2.7. Intrinsic Imaging LLC
9.2.8. Ixico PLC
9.2.9. Radiant Sage LLC
9.2.10. Worldcare Clinical, LLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption